Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Cognitia PD app lead

Resources & Tools

Mind games: can this new gaming app help Parkinson’s patients track symptoms?

New app tracks cognitive Parkinson’s symptoms

READ MORE
Heels On Head up lead

Global update

Women worldwide pose in their heels for Parkinson’s awareness

Young onset PD awareness campaign ‘Heels On Head Up’

READ MORE
WPC highlights lead

Global update

5 inspirational moments from the World Parkinson Congress 2016

More than 4,600 people from 67 different countries came together in Portlan

READ MORE